CA1005061A - Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives - Google Patents

Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives

Info

Publication number
CA1005061A
CA1005061A CA181,860A CA181860A CA1005061A CA 1005061 A CA1005061 A CA 1005061A CA 181860 A CA181860 A CA 181860A CA 1005061 A CA1005061 A CA 1005061A
Authority
CA
Canada
Prior art keywords
tetracarboxy
tricarboxy
preparation
dihydropyridine derivatives
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA181,860A
Other languages
English (en)
Inventor
Friedrich Bossert
Horst Meyer
Wulf Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA1005061A publication Critical patent/CA1005061A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA181,860A 1972-09-30 1973-09-25 Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives Expired CA1005061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722248150 DE2248150A1 (de) 1972-09-30 1972-09-30 Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
CA1005061A true CA1005061A (en) 1977-02-08

Family

ID=5857927

Family Applications (1)

Application Number Title Priority Date Filing Date
CA181,860A Expired CA1005061A (en) 1972-09-30 1973-09-25 Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives

Country Status (22)

Country Link
US (1) US3905983A (US06650917-20031118-M00005.png)
JP (1) JPS5647905B2 (US06650917-20031118-M00005.png)
AT (1) AT330175B (US06650917-20031118-M00005.png)
AU (1) AU476129B2 (US06650917-20031118-M00005.png)
BE (1) BE805451A (US06650917-20031118-M00005.png)
CA (1) CA1005061A (US06650917-20031118-M00005.png)
CH (3) CH583703A5 (US06650917-20031118-M00005.png)
CS (3) CS178440B2 (US06650917-20031118-M00005.png)
DD (1) DD110659A5 (US06650917-20031118-M00005.png)
DE (1) DE2248150A1 (US06650917-20031118-M00005.png)
DK (1) DK137722C (US06650917-20031118-M00005.png)
ES (3) ES419193A1 (US06650917-20031118-M00005.png)
FR (1) FR2201095B1 (US06650917-20031118-M00005.png)
GB (1) GB1389509A (US06650917-20031118-M00005.png)
HU (1) HU166357B (US06650917-20031118-M00005.png)
IE (1) IE38335B1 (US06650917-20031118-M00005.png)
IL (1) IL43329A (US06650917-20031118-M00005.png)
LU (1) LU68530A1 (US06650917-20031118-M00005.png)
NL (1) NL7313422A (US06650917-20031118-M00005.png)
PL (3) PL92079B1 (US06650917-20031118-M00005.png)
SE (1) SE403777B (US06650917-20031118-M00005.png)
ZA (1) ZA737659B (US06650917-20031118-M00005.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970662A (en) * 1975-06-19 1976-07-20 Sterling Drug Inc. 4-(3-Nitrophenyl)-2,3,5,6-pyridinetetracarboxylic acid and intermediates
DK152285C (da) * 1975-07-02 1988-10-10 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
US4055588A (en) * 1976-02-20 1977-10-25 Sterling Drug Inc. Tetra-(lower-alkyl)3-(3-nitrophenyl)-1,5-pentanedione-1,2,4,5-tetracarboxylates
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
DE3022002A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-4-carbonsaeureamide, verfahren zu deren herstellung, sowie diese enthaltende arzneimittel
CS228917B2 (en) 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
JPS59144249U (ja) * 1983-03-16 1984-09-27 株式会社御田釦製作所 紐類の端末処理具
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
DE3629545A1 (de) * 1986-08-30 1988-03-10 Bayer Ag Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 1,4−ジヒドロピリジン誘導体
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
SE403777B (sv) 1978-09-04
IE38335L (en) 1974-03-30
NL7313422A (US06650917-20031118-M00005.png) 1974-04-02
FR2201095B1 (US06650917-20031118-M00005.png) 1977-09-09
ZA737659B (en) 1974-08-28
JPS5647905B2 (US06650917-20031118-M00005.png) 1981-11-12
PL91085B1 (US06650917-20031118-M00005.png) 1977-02-28
DE2248150A1 (de) 1974-04-04
DK137722B (da) 1978-04-24
CS178441B2 (US06650917-20031118-M00005.png) 1977-09-15
IL43329A0 (en) 1973-11-28
ES419193A1 (es) 1976-12-16
DD110659A5 (US06650917-20031118-M00005.png) 1974-01-05
JPS4970977A (US06650917-20031118-M00005.png) 1974-07-09
CH605752A5 (US06650917-20031118-M00005.png) 1978-10-13
CS178440B2 (US06650917-20031118-M00005.png) 1977-09-15
CS178435B2 (US06650917-20031118-M00005.png) 1977-09-15
FR2201095A1 (US06650917-20031118-M00005.png) 1974-04-26
PL92084B1 (US06650917-20031118-M00005.png) 1977-03-31
ES443521A1 (es) 1977-05-16
LU68530A1 (US06650917-20031118-M00005.png) 1973-12-10
GB1389509A (en) 1975-04-03
ES443522A1 (es) 1977-05-01
DK137722C (da) 1978-10-02
CH601233A5 (US06650917-20031118-M00005.png) 1978-06-30
IL43329A (en) 1977-04-29
ATA834773A (de) 1975-09-15
HU166357B (US06650917-20031118-M00005.png) 1975-03-28
AU6071673A (en) 1975-03-27
CH583703A5 (US06650917-20031118-M00005.png) 1977-01-14
AT330175B (de) 1976-06-25
US3905983A (en) 1975-09-16
IE38335B1 (en) 1978-02-15
PL92079B1 (US06650917-20031118-M00005.png) 1977-03-31
AU476129B2 (en) 1976-09-09
BE805451A (fr) 1974-03-28

Similar Documents

Publication Publication Date Title
CA1025447A (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA1005061A (en) Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA1016544A (en) Process for the preparation of bicyclic derivatives of 1,4-dihydropyridine
CA989827A (en) Process for the preparation of 14-hydroxymorphinan derivatives
CA1027951A (en) Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
CA1007659A (en) Process for the preparation of 3,4,5-trimethoxybenzaldehyde
CA1027950A (en) Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
CA999869A (en) Process for the preparation of 2-amino-1,4-dihydropyridine derivatives
CA1027952A (en) Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
AU471079B2 (en) 5, 9, 13-prostatrienoic acid derivatives and process for their preparation
CA963469A (en) 3-substituted-as-triazino (5,6,-c) quinoline derivatives and a process for the preparation thereof
CA988524A (en) Process for the preparation of 2,6-diamino-1,4-dihydropyridine derivatives
CA1003841A (en) 2,10-dichloro-12-methyl-12h-dibenzo(d,g)(1,3)dioxocine derivatives and a process for the preparation of same
CA993871A (en) Process for the preparation of certain indolobenzazepine derivatives
CA1030151A (en) Process for producing 9,10-seco-oestrane derivatives
CA1027973A (en) Process for the preparation of 1,2-dichloroethane
CA982126A (en) Benzotriazocine derivatives and process for the preparation thereof
CA998677A (en) Process for the preparation of 2-substituted-1,3,4-thiadiazole-5-thiols
CA894243A (en) Process for the preparation of 9-pyridylalkyl-1,2,8,9-tetraazaphenale nes
GB1374382A (en) Process for the preparation of derivatives of 1,2-diphenyl-3,5- dioxo-4-n-butylpyrazolidine
CA898806A (en) Process for the preparation of 1,4-benzodiazepine derivatives
CA873886A (en) Process for the preparation of 1,3-benzoxazin derivatives
CA1025453A (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA894805A (en) Process for the preparation of dibenzo-cycloheptene derivatives
CA913103A (en) Process for the preparation of isoquinuclidine derivatives